baber/WOPTO huggingface dataset:
Patent FI-915597-A0 (FI)
Inventor: RANTASUO MARKKU
IPC: H04N5/33
Filed: 1991-11-27
Abstract: PCT No. PCT/FI92/00325 Sec. 371 Date Jul. 18, 1994 Sec. 102(e) Date Jul. 18, 1994 PCT Filed Nov. 27, 1992 PCT Pub. No. WO93/11630 PCT Pub. Date Jun. 10, 1993A method for creating a false color image, by utilizing a video camera provided with two or three arrays of semiconductor detectors, the sensitivity range whereof, in relation to wavelength, extends from the visible light range to near infrared radiation range, and where the radiation received in the semiconductor detectors is filtered. The radiation received in the first array of semiconductor detectors is filtered so that only near infrared radiation is given access to the detector array. Further, the radiation received in the second semiconductor detector array, or alternatively in the second and third semiconductor detector arrays is filtered so that of the radiation of the visible spectrum range, green and red are given access to the detector array or arrays. The signals obtained from the first and second semiconductor detector arrays, or alternatively from the first, second and third semiconductor detector arrays, representing the strength of near infrared radiation and the strength of the radiation of the green and red spectrum ranges, are decoded by changing the order of the signals in order to achieve a desired false color signal in the camera output.
Patent FI-930960-A0 (FI)
Inventor: LAWRENCE GEORGE A
IPC: B03D1/14
Filed: 1993-03-04
Abstract: The invention relates to an improved flotation cell design for the mining industry. The flotation cell includes a cylindrical froth flotation unit 52 and a unique hexagonal overflow froth launder 84. The design optimizes the froth flotation process and allows for the economical utilization of the honeycomb packing arrangement of cells.   <IMAGE>
Patent FI-931946-A0 (FI)
Inventor: ABBOTT RONALD GORDON
IPC: B01J31/02
Filed: 1993-04-29
Abstract: A novel alkylation catalyst is described which is used in processes for alkylating olefin hydrocarbons with isoparaffin hydrocarbons to produce high octane alkylate products suitable for use as a blending component of gasoline motor fuel. The novel catalyst comprises a mixture of a hydrogen halide and a sulfone. The novel alkylation catalyst is utilized in a novel process for alkylating olefin hydrocarbons with isoparaffin hydrocarbons. <IMAGE>
Patent FI-932117-A0 (FI)
Inventor: HAUK KLAUS
IPC: B60R16/02
Filed: 1993-05-10
Abstract: A wire harness for a motor vehicle is described having at least one cab wire harness plug (20) which can be attached to the cab (14) of the vehicle and whose poles are electrically connected to current collectors, control and display devices in the cab (14) of the vehicle and having at least one further wire harness plug (126, 204) which can be connected electrically to the wire harness plug (20) and whose poles are connected to electrical equipment parts of at least one vehicle component, for example engine (110) or transmission (192). For a simple, installation-friendly structure it is proposed that at least one main fuse (90, 150) and/or one high-current relay (146) and a connection facility (106, 182) for an external starting device be integrated in the housing of the cab wire harness plug (20) and/or the housing of the further wire harness plug (126, 204). The connection device is preferably constructed as a bolt-shaped earthing pin (106) or bolt-shaped positive pin (182) for the optional connection of an external starting device and is electrically connected to the chassis of the vehicle or to the battery of the vehicle via at least one fuse (150) which is integrated in the plug-in connection. The plug-in connection between two or more wire harnesses is constructed as a power-branching point. <IMAGE>
Patent FI-933581-A0 (FI)
Inventor: ASCHE GUENTER
IPC: B61D3/00
Filed: 1993-08-13
Abstract: In order to be able to use a railway fleet car which is of lightweight and economical design universally within a train configuration both as an end car and as a central car, it being possible for a customary UIC coupling interface to be made available as required at each end of the car, the end regions of the underframe (1) are of identical design without permanently connected buffer brackets and a receptacle bearing (2) is arranged in each end region of the underframe (1) at the same distance from the end side in the vertical longitudinal centre plane, by means of which receptacle bearing (2) either a coupling rod (3) or a buffer bracket (4) with draw and buffer gear (5) can be releasably attached to the underframe (1) and supported therewith. <IMAGE>
Patent FI-950972-A0 (FI)
Inventor: LIER ROLF
IPC: B65D35/40
Filed: 1995-03-02
Abstract: PCT No. PCT/EP93/02333 Sec. 371 Date Mar. 6, 1995 Sec. 102(e) Date Mar. 6, 1995 PCT Filed Aug. 28, 1993 PCT Pub. No. WO94/05586 PCT Pub. Date Mar. 17, 1994A package for free-flowing products comprising a product container and a closable applicator point fitted on its outlet aperture provides precise metering of the quantity of product expelled regardless of the level in the package, and while ensuring easy handling. The product container consists of an extruded receptacle of aluminum having externally depressible walls which spring back when the pressure is released.
Patent FI-953590-A0 (FI)
Inventor: CHIESI PAOLO
IPC: A61K47/48
Filed: 1995-07-27
Abstract: PCT No. PCT/EP94/00205 Sec. 371 Date Nov. 15, 1995 Sec. 102(e) Date Nov. 15, 1995 PCT Filed Jan. 26, 1994 PCT Pub. No. WO94/16733 PCT Pub. Date Aug. 4, 1994A multicomponent inclusion complex of a basic drug, an acid and a cyclodextrin has enhanced water-solubility.
Patent AP-9600894-A0 (AP)
Title: Contaminant recovery system and method.
Inventor: SUTHERLAND GEORGE
IPC: C02F1/00
Filed: 1995-06-23
Abstract: There is disclosed a system for separating oil and other immiscible contaminants from a liquid body containing the contaminants such as a water body. The system includes the use of a plurality of microporous hollow fibers 16, 18 which may be arranged in any number of arrangements such as bundles, intersecting arrangements, divergent patterns or in a mat-like arrangement or a combination of the foregoing. The hollow fibers are in communication with a souce of suction 28 in order to draw the contaminant via the pores into the fibers for subsequent storage in a suitable container 20, 22. By incorporating acceptable means of density control a substantial amount of the hollow fiber surface area may be exposed to the contaminant thus increasing the extraction efficiency of the contaminant from the water boby. The unit optionally may be self-contained. This system provides a substantial advantage over existing arrangements in that extraction efficiency is greatly enhanced in any number of environments.
Patent IL-65666-A0 (IL)
Title: 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
IPC: C07D401/06
Filed: 1982-05-02
Abstract: 1,3-Dihydro-2H-imidazol-2-ones having 5-acyl and 4-(substituted amino)methyl substituents, are useful as cardiotonics, antihypertensives and antithrombotic agents. The compounds are obtained by the reaction of an appropriate amine with a substituted 4-bromomethyl-1,3-dihydro-2H-imidazol-2-one.
Patent IL-75742-A0 (IL)
Title: Phenylethylaminopropiophenone derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07C213/00
Filed: 1985-07-08
Abstract: 1. Phenylethylaminopropiophenone derivatives of the general formula (I)  see diagramm : EP0167945,P10,F4  in which R**1 represents hydrogen, lower alkyl which is optionally substituted by fluorine, or halogen, R**2 denotes hydrogen or lower alkyl and R**3 denotes hydrogen, alkoxy or halogen, and their physiologically acceptable salts with inorganic or organic acids.
Patent IL-93003-A0 (IL)
Title: Heparin fraction with anti-hiv activity
IPC: A61K31/70
Filed: 1990-01-08
Abstract: Various peptides having affinity for sulfated polysaccharides such as heparin, dextran sulfate and pentosan polysulfate are bound to resins and used in affinity chromatography to prepare anti-HIV sulfated polysaccharides.
Patent IL-99497-A0 (IL)
Title: Synergistic compositions comprising tnf and il-4
IPC: A61K/
Filed: 1991-09-16
Abstract: A composition of matter which comprises Tumor Necrosis Factor (TNF) and Interleukin-4 (IL-4) has been disclosed. This composition inhibited the growth of human breast cancer cells, human vulvar carcinoma cells and human histiocytic lymphoma cells a dose-dependent manner. The growth characteristics of human breast cancer cells were minimally affected when exposed to TNF or IL-4 alone. However, the combination of these two cytokines together inhibited the growth of these cells in a dose-dependent manner. Additionally, interferon-gamma (IFN-g) caused a further potentiation of the antiproliferative effects of the TNF and IL-4 composition.
Patent FI-20001998-A0 (FI)
Inventor: NIEMELAE PEKKA
IPC: F27B21/06
Filed: 2000-09-11
Abstract: The invention relates to an arrangement and method for heating gases in a gas circulation duct in connection with continuously operated sintering. In the sintering furnace, hot gas is fed in from above the belt in order to sinter the material located on the belt, and part of the gas circulation duct is formed as a burning zone, a burner ring, where the gas is heated. The burner ring comprises at least one burner unit directed inwardly from the circumference of the gas circulation duct.
Patent FI-20022084-A0 (FI)
Inventor: VAITTINEN HENRI
IPC: D21G/
Filed: 2002-11-22
Abstract: The invention relates to a processing device for processing a coated or uncoated fibrous web, comprising a belt (2) adapted to extend around a guiding element (3), at least one roll (5) being disposed outside said belt to provide a contact area with the belt, such that the belt (2) and the roll (5) establish therebetween a web processing zone for passing a web to be processed therethrough, wherein 
outside the belt (2) is provided a deflection-compensated nip roll (26) to establish a profiling nip with the roll (5), a web (W) being adapted to travel through said profiling nip, that the processing zone length is defined by means of the disposition/adjustment of the belt's (2) guiding element (3) and/or by means of the dimensioning of the roll (5), and that a contact pressure applied to the web in the processing zone is adapted to be adjustable within the range of about 0.01 MPa to about 200 MPa, and that 
the roll (5) comprises a thermal roll, that the belt (2) comprises a metal belt, and that the operating temperature of the thermal roll (5) and/or the metal belt lies within the range of about 50°C to about 400°C, and 
the belt having a thickness of about 0,1 to 3 mm.
Patent IL-110148-A0 (IL)
Title: Heat exchanger
IPC: F28D1/04
Filed: 1994-06-28
Abstract: A heat exchanger consists of a plurality of exchange tubes (1) arranged parallel to one another. For the passage of one of the media participating in the heat exchange, the cross-section of the exchange tubes has a width which is large in relation to the height. Fastened to each of the two flat sides (2) of the exchange tubes (1) are ribs (3) which are formed from a ribbed band (strip) (4) which is multiply deflected in a meandering fashion. In order to reduce the influence of any possible pollutants (pollution) on the heat transfer performance of the heat exchanger, the ribs (3) are provided with a plurality of openings (9). The cross-sections of these openings are respectively at least as large as the cross-section (Q), through which flow occurs, between two adjacent ribs (3). The ribs (3) are preferably fastened to the flat sides (2) of the exchange tubes (1) by means of a capacitor discharge welding process. <IMAGE>
Patent IL-110870-A0 (IL)
Title: Optical fibre organizer
IPC: G02B6/24
Filed: 1994-09-05
Abstract: PCT No. PCT/GB94/01910 Sec. 371 Date Mar. 6, 1996 Sec. 102(e) Date Mar. 6, 1996 PCT Filed Sep. 2, 1994 PCT Pub. No. WO95/07483 PCT Pub. Date Mar. 16, 1995An optical fibre organizer, which comprises: 1. first and second ports through which optical fibres can pass; 2. an organizer drum positioned with respect to the ports such that a fibre passing between them is constrained by an outer surface of the drum to a minimum bend radius at least equal to the critical bend radius of that fibre; in which the drum is hollow allowing a free end of the fibre to pass from one of the ports to the interior of the drum and to be stored therein at a minimum bend radius greater than at which it suffers permanent damage.
Patent IL-127331-A0 (IL)
Title: Peptide-based vaccine for influenza
IPC: A61P27/16
Filed: 1998-11-30
Abstract: A human synthetic peptide-based influenza vaccine for intranasal administration comprises a mixture of flagella containing at least four epitopes of influenza virus reactive with human cells, each expressed individually in Salmonella flagellin, said influenza virus epitopes being selected from the group consisting of: (i) one B-cell hemagglutinin (HA) epitope; (ii) one T-helper hemagglutinin (HA) or nucleo-protein (NP) epitope that can bind to many HLA molecules; and (iii) at least two cytotoxic lymphocyte (CTL) nucleoprotein (NP) or matrix protein (M) epitopes that are restricted to the most prevalent HLA molecules in different human populations.
Patent IL-128129-A0 (IL)
Title: Uses of wnt polypeptides
IPC: A61K38/22
Filed: 1997-08-07
Abstract: Uses for Wnt polypeptides in hematopoiesis are disclosed. In particular, in vitro and in vivo methods for enhancing proliferation or differentiation of a hematopoietic stem/progenitor cell using a Wnt polypeptide, and optionally another cytokine, are described.
Patent IL-151141-A0 (IL)
Title: Method for classifying and treating physiologic brain imbalances using quantitative eeg
IPC: A61B5/00
Filed: 2001-02-09
Abstract: The present invention relates to a method for determining medication efficacy, comprising: 
a) providing; 
i) a patient having a physiologic brain imbalance, wherein said imbalance is identified using a first electroencephalography recording, and 
ii) a medication; and,  
b) converting said first electroencephalography recording to at least one first multivariate outcome measurement wherein said first outcome measurement comprises a plurality of first univariate Z scores, wherein said first multivariate outcome measurement is derived from a frequency band selected from the group consisting of delta, theta, alpha, and beta; 
c) administering said medication to said patient; 
d) obtaining a second electroencephalography recording from said patient and converting said second electroencephalography recording to at least one second multivariable outcome measurement wherein said second outcome measurement comprises a plurality of second univariate Z scores, wherein said second multivariate outcome measurement is derived from a frequency band selected from the group consisting of delta, theta, alpha, and beta; and 
e) comparing said first multivariate outcome measurement with said second multivariate outcome measurement wherein a differential change between said first and second measurement determines said medication efficacy.
Patent IL-151399-A0 (IL)
Title: Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
IPC: A61K47/42
Filed: 2001-03-01
Abstract: Amino acid sequences (I) that facilitate penetration of a substance of interest (II) into the inside of a cell and/or its nucleus. (I) can react in vivo with aminoglycans (AG) or can react with AG (sic) and are derived from proteins of human origin. Independent claims are also included for the following: (1) associations of (I) and (II); (2) intracytoplasmic and/or intranuclear transfer vectors consisting of, or containing, at least one (I); (3) eukaryotic cells that contain (I) or the vector of (2) or are transfected with this vector; (4) process for in vitro transfer of (II) into cells; (5) composition (biological, pharmaceutical, cosmetic, nutritional, diagnostic or tracer) containing as active agent a vector of (2) or a cell of (3); (6) diagnostic agent comprising the vector of (2) or the cells of (3); and (7) diagnostic kit containing, in one or more vessels, a predetermined quantity of the composition of (5). ACTIVITY : Antiviral; antibacterial; cytostatic; anti-apoptotic; vasotropic; hemostatic. No supporting data given. MECHANISM OF ACTION : Gene or protein replacement; gene therapy. No supporting data given.
Patent IL-153394-A0 (IL)
Title: Process for the preparation of 5-aminosalicyclic acid
IPC: C07C227/04
Filed: 2001-06-12
Abstract: The present invention relates to a new process for the electrochemical preparation of p-aminophenols, especially 5-aminosalicylic acid. The process can be performed at a low temperature of below 50° C.
Patent IL-159358-A0 (IL)
Title: Elicitor made from trigonella foenum graecum seed extracts and use thereof in controlling pathogenic organisms of plants
IPC: A01P21/00
Filed: 2002-06-14
Abstract: The invention relates to a method for controlling pathogenic organisms of agronomically useful plants by means of a novel elicitor and to a composition for implementing said method. Said method for controlling pathogenic organisms of agronomically useful or ornamental plants is essentially characterized in that a novel elicitor contained in the seed extracts of Trigonella foenum graccum is applied to said plants. Said elicitor is applied in the precocious or mature growth states.
Patent IL-169334-A0 (IL)
Title: Phthalazine derivatives as phosphodiesterase 4 inhibitors
IPC: A61P29/00
Filed: 2005-06-21
Abstract: Compounds of formula I wherein R and R<SUB>1 </SUB>are as defined in the description. The compounds of formula I are PDE 4 inhibitors.
Patent IL-182531-A0 (IL)
Title: Method and apparatus for supervising a potentially gated signal in a wireless communication system
IPC: H04L1/20
Filed: 2007-04-12
Abstract: Apparatus and method for use in a mobile station in a wireless communication system, comprising in which: 
a decoder (218) detects if frames received from a base station are good or bad; 
a first counter (224) counts received bad frames; 
a second counter (226) counts received good frames; 
a control processor for resets the first counter (224) to zero and incrementing the second counter (226) by one if a received frame is declared a good frame, and incremens the first counter (224) by one and resetting the second counter (226) to zero if a received frame is declared a bad frame, and disables a transmitter if the value of the first counter (224) reaches a predetermined threshold.
Patent IL-184519-A0 (IL)
Title: Protease inhibitor precursor synthesis
Filed: 2007-07-10
Abstract: The present invention provides a compound having the structure (I) and processes for the production thereof and the intermediates used in such process.
Patent IL-186655-A0 (IL)
Title: Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
Filed: 2007-10-15
Abstract: Object of the invention are mucoadhesive and controlled release formulations consisting of aqueous solutions containing 0.05% to 5% by weight of a natural purified polymer having xyloglucan structure and 10% to 70% by weight of glycerol. These formulations are suitable for the application on human mucous membranes, such as nasal, oral and vaginal mucous membranes, as moisturizing and softening agents or as pharmaceutical release system. Further objects of the invention are pharmaceutical formulations and medical devices suitable for the application to human mucous membranes, containing the mucoadhesive and controlled release formulations together with active ingredients and excipients.
Patent IL-195234-A0 (IL)
Title: Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
Filed: 2008-11-11
Abstract: The invention relates to fused bicycloheterocycle substituted azabicyclic alkane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
Patent IL-196177-A0 (IL)
Title: Thin film multilocular structure made of collagen, member for tissue regeneration containing the same, and method for producing the same
Filed: 2008-12-25
Abstract: The present invention provides a new structure made of collagen for improving promotion of nerve tissue regeneration, curing and regeneration of a defective part of a soft biological tissue and so on without using laminin or nerve growth factor (NGF), and a member for tissue regeneration including the same. The structure made of collagen according to the present invention has a thin film multilocular formation and therefore a new structure different from a colloid form, a gel form, and a fiber form. Therefore, when the new structure made of collagen according to the present invention is used as a member for tissue regeneration, surprisingly, promotion of regeneration, shortening of a treatment period, functional recovery, or the like of bodily tissue such as nerve tissue, subdermal tissue, submucosal tissue, membranous tissue, fat tissue, muscle tissue, skin tissue, and gingival tissue can be improved. Furthermore, when the structure according to the present invention is used to a patient having neuropathic pain, the member has an effect on the disappearance of the pain.
Patent RO-131890-A0 (RO)
Title: Safety coupling with balls
Inventor: POPA SILVIU
IPC: F16D7/10
Filed: 2017-01-10
Abstract: The invention relates to a safety coupling with balls meant to transmit the rotation moment and motion in both directions, between two consecutive coaxial elements of a kinematic linkage, and to limit the transmitted moment of rotation in case that overloads occur in operation. According to the invention, the coupling has two semicouplings (1 and 2) mounted on a toothed wheel, either a belt or a chain pulley, and on a shaft, respectively, some spherical active recesses (a) made by deep drawing in some disk springs (4), mounted by means of their profile into some spherical recesses (b) provided on the central front parts of the second semicoupling (2) and some balls (3) which are arranged, on the one hand, in some spherical recesses (c) of the first semicoupling (1) and, on the other hand, in the active recesses (a) of the disc springs (4), in the disengaging process, where the balls (3) compress the disc springs (4), rolling thereon, in the completely engaged operation and in the disengaging process, the first semicoupling (1) rests on the second semicoupling (2) by means of some radial bearings (6), the semicouplings (1 and 2) and the disc springs (4) being axially fixed by means of some spacers (5), the bearings (6) and some safety rings (7).
Patent RO-132790-A0 (RO)
Title: Nano-capacitive accumulator with integrated hydraulic transport system for electric energy transfer and charging station
Inventor: PANAIT FILIP
IPC: H02J15/00
Filed: 2018-03-06
Abstract: The invention relates to a nano-capacitive accumulator for storing electric energy. According to the invention, the nano-capacitive accumulator (14) comprises several nano-capacitors included in a circular structure provided with a central area with two electrically-charged surfaces (1, 2) with depression, and a peripheral surface with elevation comprising an insulating ring (3). The nano-capacitive accumulators are dispersed, in a high number, in a dielectric fluid (20) circulating through a hydraulic transport system inside of which there is a capillary transfer system (12), which provides the taking-over of the electric energy stored by each accumulator (14), by means of commutator brushes (13a, 13b), and transfers it to the final consumers (18).